This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Berger, J. M. Articles by Harrison, P. Search for Related Content PubMed PubMed Citation Articles by Berger, J. M. Articles by Harrison, P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Cancer Pain Hazardous Substances DB FENTANYL KETAMINE HYDROCHLORIDE MIDAZOLAM HYDROCHLORIDE Social Bookmarking                   What's this?

Ketamine-fentanyl-midazolam infusion for the control of symptoms in terminal life care

Department of Anesthesiology, Pain Management Service, University of Southern California, Keck School of Medicine, Los Angeles, California

Angèle Ryan, MD

Department of Anesthesiology, Pain Management Service, University of Southern California, Keck School of Medicine, Los Angeles, California

Nalini Vadivelu, MD

Department of Anesthesiology, Pain Management Service, University of Southern California, Keck School of Medicine, Los Angeles, California

Pamela Merriam, RN, MSN, OCN

Department of Anesthesiology, Pain Management Service, University of Southern California, Keck School of Medicine, Los Angeles, California

Linda Rever, MD

Department of Anesthesiology, Pain Management Service, University of Southern California, Keck School of Medicine, Los Angeles, California

Patricia Harrison, MD

Department of Anesthesiology, Pain Management Service, University of Southern California, Keck School of Medicine, Los Angeles, California

In this report, we describe nine terminally ill patients with metastatic cancer who were treated with an intravenous infusion consisting of ketamine (2 mg/ml)/fentanyl (5g/ml)/midazolam (0.1 mg/ml) (K/F/M) to control pain after traditional analgesic therapies were unsuccessful. In addition to pain, all patients exhibited some symptoms of cognitive compromise and agitation. After initiation of the K/F/M infusion, all patients exhibited some degree of qualitative improvement in these symptoms as well as in overall pain control. We feel that these observations warrant reporting of the efficacy of this infusion for the treatment of uncontrolled pain and agitation in terminally ill patients when the traditional methods of pain control are inadequate.

American Journal of Hospice and Palliative Medicine®, Vol. 17, No. 2, 127-134 (2000)
DOI: 10.1177/104990910001700213


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. G. Fine The Evolving and Important Role of Anesthesiology in Palliative Care Anesth. Analg., January 1, 2005; 100(1): 183 - 188. [Abstract] [Full Text] [PDF]

				R. Schmid, G. Koren, J. Klein, and J. Katz The Stability of a Ketamine-Morphine Solution Anesth. Analg., April 1, 2002; 94(4): 898 - 900. [Abstract] [Full Text] [PDF]